ATE481973T1 - Verfahren zur behandlung einer akuten gefässerkrankung - Google Patents
Verfahren zur behandlung einer akuten gefässerkrankungInfo
- Publication number
- ATE481973T1 ATE481973T1 AT07709154T AT07709154T ATE481973T1 AT E481973 T1 ATE481973 T1 AT E481973T1 AT 07709154 T AT07709154 T AT 07709154T AT 07709154 T AT07709154 T AT 07709154T AT E481973 T1 ATE481973 T1 AT E481973T1
- Authority
- AT
- Austria
- Prior art keywords
- mammal
- acute vascular
- vascular disease
- treating acute
- steroid
- Prior art date
Links
- 230000001154 acute effect Effects 0.000 title abstract 2
- 208000019553 vascular disease Diseases 0.000 title abstract 2
- 241000124008 Mammalia Species 0.000 abstract 3
- 239000000126 substance Substances 0.000 abstract 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 2
- 239000002243 precursor Substances 0.000 abstract 2
- 150000003431 steroids Chemical class 0.000 abstract 2
- 206010059245 Angiopathy Diseases 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US75702706P | 2006-01-09 | 2006-01-09 | |
| EP06100159 | 2006-01-09 | ||
| PCT/NL2007/050006 WO2007081206A1 (en) | 2006-01-09 | 2007-01-09 | A method of treating an acute vascular disorder |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE481973T1 true ATE481973T1 (de) | 2010-10-15 |
Family
ID=36100928
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT07709154T ATE481973T1 (de) | 2006-01-09 | 2007-01-09 | Verfahren zur behandlung einer akuten gefässerkrankung |
Country Status (4)
| Country | Link |
|---|---|
| CN (1) | CN101378762A (de) |
| AT (1) | ATE481973T1 (de) |
| DE (1) | DE602007009358D1 (de) |
| ES (1) | ES2352547T3 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3701944B1 (de) | 2015-06-18 | 2021-12-08 | Estetra SRL | Schmelzende darreichungseinheit mit einer estetrolkomponente |
| CU24523B1 (es) * | 2015-06-18 | 2021-06-08 | Estetra Sprl | Unidad de dosificación orodispersable que contiene un componente estetrol |
| CA3178291A1 (en) | 2016-08-05 | 2018-04-12 | Estetra Srl | Method for the management of dysmenorrhea and menstrual pain |
| TWI801561B (zh) | 2018-04-19 | 2023-05-11 | 比利時商依思特拉私人有限責任公司 | 化合物及其用於緩解絕經相關症狀的用途 |
| TWI893101B (zh) | 2020-04-16 | 2025-08-11 | 比利時商埃斯特拉有限責任公司 | 具有降低之副作用之避孕組成物 |
-
2007
- 2007-01-09 AT AT07709154T patent/ATE481973T1/de not_active IP Right Cessation
- 2007-01-09 DE DE602007009358T patent/DE602007009358D1/de active Active
- 2007-01-09 CN CNA2007800045937A patent/CN101378762A/zh active Pending
- 2007-01-09 ES ES07709154T patent/ES2352547T3/es active Active
Also Published As
| Publication number | Publication date |
|---|---|
| DE602007009358D1 (de) | 2010-11-04 |
| CN101378762A (zh) | 2009-03-04 |
| ES2352547T3 (es) | 2011-02-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE534377T1 (de) | Verfahren und zusammensetzungen zur behandlung von hämatologischen erkrankungen | |
| DE602008001783D1 (de) | Verfahren zur behandlung oder prävention von unfruchtbarkeit bei weiblichen säugern und pharmazeutisches kit zur anwendung dieses verfahrens | |
| ATE533492T1 (de) | Behandlung oder prävention von hypertensiven erkrankungen in der schwangerschaft oder von wachstumsverzögerung des foeten | |
| ATE340580T1 (de) | Verwendung von zusammensetzungen enthaltend ein oestrogen zur behandlung und verhinderung von muskelskelettschmerzen | |
| DK1446128T3 (da) | Anvendelse af östrogenforbindelser i kombination med progestogenforbindelser i hormonsubstitutionsbehandling | |
| MX2009008439A (es) | Nuevos inhibidores de la replicacion del virus de hepatitis c. | |
| TN2009000012A1 (en) | Amino-piperidine derivatives as cetp inhibitors | |
| EA200701176A1 (ru) | Новые соединения нафталина, способ их получения и фармацевтические композиции, содержащие их | |
| TW200740773A (en) | Diaminopyrimidines as P2X3 and P2X2/3 modulators | |
| BRPI0712101B8 (pt) | ácido beta-fenil-alfa-hidróxi propanóico substituído, método de síntese e uso do mesmo | |
| ECSP099330A (es) | Compuesto de indol | |
| ATE536349T1 (de) | In der 2-stellung durch phenyl substituierte 1h- benzimidazol-4-carbonsäureamide sind wirksame parp-inhibitoren | |
| EA200971026A1 (ru) | Новые макроциклические ингибиторы репликации вируса гепатита с | |
| BRPI0615111B8 (pt) | composto, composição farmacêutica, e, uso do composto | |
| BR112012009214A2 (pt) | compostos | |
| DE602007009358D1 (de) | Verfahren zur behandlung einer akuten gefässerkrankung | |
| MX2009000657A (es) | Composiciones y metodos para el tratamiento de mucositis. | |
| ATE533489T1 (de) | Behandlung von multiplem myelom | |
| MX2009011205A (es) | Derivados de 2-iminoisotiazol como ligandos del receptor canabinoide. | |
| MX2009005795A (es) | Composiciones, sintesis y metodos para usar inhibidores de colinesterasa basados en indanona. | |
| ATE522532T1 (de) | Verbindungen zur behandlung von hepatitis c | |
| ATE494291T1 (de) | Verbindungen zur behandlung von hepatitis c | |
| MX2009012374A (es) | Compuestos novedosos como ligandos del receptor de canabinoides. | |
| MA32943B1 (fr) | Piperidine spiro pyrrolidione et piperidinone substituees, leur preparation et leur utilisation therapeutique | |
| DE60333901D1 (de) | Verfahren zur reduzierung der angiogenese |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |